Abdominal Aortic Aneurysms Clinical Trial
Official title:
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Verified date | March 2016 |
Source | Cook |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The Zenith(R) Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.
Status | Completed |
Enrollment | 42 |
Est. completion date | September 2015 |
Est. primary completion date | February 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm Exclusion Criteria: - Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal - Renal artery stenosis greater than 50 percent |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
United States | University of North Carolina | Chapel Hill | North Carolina |
United States | Cleveland Clinic | Cleveland | Ohio |
United States | Shands Hospital | Gainesville | Florida |
United States | The Indiana Heart Hospital | Indianapolis | Indiana |
United States | Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire |
United States | NYU Medical Center | New York | New York |
United States | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania |
United States | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania |
United States | Mayo Clinic | Rochester | Minnesota |
United States | University of California, San Francisco | San Francisco | California |
United States | Harborview Medical Center | Seattle | Washington |
United States | Barnes-Jewish Hospital | St. Louis | Missouri |
United States | University of Massachusetts | Worcester | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Cook |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With Treatment Success | Technical success (successful access, deployment, and patency of the Fenestrated Graft, and patency of all vessels targeted by a fenestration intra-operatively), and freedom from the following: type I or type III endoleaks, AAA-related serious adverse events, AAA-related major complications, and aneurysm enlargement greater than 0.5 cm. A serious adverse event is defined as any occurrence of death, aneurysm rupture, or conversion to open surgical repair. A major complication is defined as any occurrence of Q-wave myocardial infarction, congestive heart failure, cardiac ischemia requiring intervention, renal failure requiring permanent dialysis, bowel obstruction, ischemia, or fistula, stroke with permanent deficit, or paralysis. |
6 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02888613 -
Mini-laparotomy Versus Mini Lumbotomy
|
N/A | |
Recruiting |
NCT00662480 -
Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark
|
Phase 4 | |
Terminated |
NCT00372138 -
Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms
|
N/A | |
Completed |
NCT00989729 -
Preoperative Methylprednisolone in Endovascular Aortic Repair
|
N/A | |
Active, not recruiting |
NCT02345005 -
Iliac Branch Excluder ReGistry (IceBERG)
|
||
Completed |
NCT01390740 -
Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey
|
||
Completed |
NCT00833924 -
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
|
N/A | |
Terminated |
NCT00610090 -
Safety Study for the Treatment of Abdominal Aortic Aneurysms
|
Phase 2 | |
Completed |
NCT02477111 -
European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
|
||
Recruiting |
NCT01538056 -
Physician Modified Endovascular Grafts
|
N/A | |
Completed |
NCT01106391 -
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
|
N/A | |
Terminated |
NCT00444821 -
The (PIVOTAL) Study
|
N/A | |
Completed |
NCT01599533 -
Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm
|
N/A | |
Completed |
NCT01328197 -
Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
|
Phase 1 | |
Completed |
NCT00705718 -
Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System
|
N/A | |
Completed |
NCT02125890 -
Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms
|
Phase 3 | |
Completed |
NCT02048514 -
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
|
N/A | |
Terminated |
NCT00546013 -
Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome
|
N/A | |
Recruiting |
NCT05004051 -
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
|
||
Withdrawn |
NCT03965364 -
China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)
|